TLR9 and systemic lupus erythematosus: For instance, PBMCs obtained from patients with systemic lupus erythematosus that were treated with 50 nM of VitD3 express lower levels of TLR3, TLR7, and TLR9 compared to non-treated PBMCs [40], as observed in this study.